Come on in and join us ! @KonradWagstyl and I have a fully-funded 4 yr PhD-ship open thru the super NIMH-UCL (D.C/London) graduate program partnership (shorturl.at/Qr5uq). Bridge Macro<-> views of 🧠 wt neuroimaging & omics (e.g. shorturl.at/W2cgo). Pls DM/apply ! 😃

JUST OUT in Nature Mental Health: Mapping functional connectivity in youth with depression Largest fMRI sample of youth with MDD curated to date Are depression-related FC changes in youth consistent with those in adults? New work by Connie Nga Yan Tse & Robin Cash & team

Where should we target TMS to treat #PTSD? New paper by Shan Siddiqi @shansiddiqi.bsky.social Center For Brain Circuit Therapeutics out today in Nature Neuroscience identifies a target based on focal brain lesions.

What are the key milestones in Alzheimer’s disease research? In the article "The History of Alzheimer’s Disease," the editors of Nature journals share their insights on this topic. The BioFINDER team is particularly proud to have contributed to a significant milestone in 2020.

A new study by Drs. Peter Zhukovsky Daniel Felsky and Aristotle Voineskos is shedding light on the importance of treating risk factors – such as depression and cardiovascular disease – to help minimize the risk of cognitive disorders later in life. psychiatry.utoronto.ca/news/can-genet… #ImPACT

An increase in amygdala reactivity was associated with risk of relapse after antidepressant discontinuation and may represent a functional neuroimaging marker that could inform clinical decisions around antidepressant discontinuation. ja.ma/4elvQjQ

#SOBP2025 is happening in Toronto this year!🇨🇦 Really excited to attend for the first time & present exciting work on the relationships between functional connectivity x cognition in collaboration with Peter Zhukovsky 🙌🏻 If you’re also attending #SOBP2025, let’s connect!

1/18: Well, after 23 years as faculty at Harvard and almost 15 years of amazing collaborations, collegiality and growth at McLean Hospital, today I officially start at UC Irvine, where I will be the founding director of a new depression

‼️PhD Position now available in my lab‼️ Do you like: * Neurodegenerative disease? * Neuroimaging and/or multi-omics? * AI and data-driven life science? Want to work with RikOssenkoppele Alexandra Young and Laura Wisse? Apply here: lu.varbi.com/what:job/jobID… Please rt/share 🙏

Just launched the E2P Simulator - an interactive open-source tool that translates effect sizes into predictive utility 🧠 Check it out here: e2p-simulator.com Many areas of research, such as biomedical, behavioral, educational, and sports sciences are studying individual

We're entering a new era of #Alzheimers blood testing—fully automated platforms now deliver fast, accurate #pTau217 results for use in primary & secondary care. Proud to share senior authorship and proud of this multi-centre European collaboration. 🔗 nature.com/articles/s4159…

Hello colleagues, I have just received my first NIMH funded R01 and am looking to hire a postdoctoral fellow. Please spread the word! Here is the link for details about our team and the position! cdasr.mclean.harvard.edu/wp-content/upl…

🚀 CAN-BIND Multi-Modal Data Sets in Action at Society of Biological Psychiatry 2025! A huge shout-out to Dr. Eric Ruhé for leading a stellar symposium, with Dr. Peter Zhukovsky Peter Zhukovsky, Dr. Matthan Caan, and the CAN-BIND platform leaders Dr. Faranak Farzan Faranak Farzan & Dr. Jane Foster

Applications for our postdoc position closes in 6 days! (Deadline: May 18 11:55pm AEST) If you are interested in MRI, modelling of brain dynamics, and genetics in health, disease, or across evolution, we would love for you to join our team👇👇

Benchmarking methods for mapping functional connectivity in the brain | doi.org/10.1038/s41592… What is the best FC metric? led by Zhen-Qi Liu @[email protected] in Nature Methods ⤵️